Nina Niu Sanford: Updates to NRG GI-011 Aim to Further Facilitate Trial Accrual
Nina Niu Sanford/X

Nina Niu Sanford: Updates to NRG GI-011 Aim to Further Facilitate Trial Accrual

Nina Niu Sanford, Assistant Professor and Chief of Gastrointestinal Radiation Oncology at Harvard/Brigham and Women’s Hospital/Massachusetts General Hospital, shared a post on X:

“Here is a quick 3 min update on NRG GI-011, highlighting Amendment 2.0 changes:

  1. Liberalize post-induction chemo CA199 criteria
  2. Allow tumor treating fields
  3. Up to 8 mo induction chemo

We hope these changes further facilitate accrual. Thanks to all for your support.”

Proceed to the video attached to the post.

Other posts featuring Nina Niu Sanford on OncoDaily.